713508 |
FRONTIERS IN IMMUNOLOGY |
SARS-CoV-2 Accessory Proteins in Viral Pathogenesis: Knowns and Unknowns |
2021-07-07 |
10.3389/fimmu.2021.708264 |
Redondo Natalia, Zaldívar-López Sara, Garrido Juan J., Montoya Maria |
713507 |
FRONTIERS IN IMMUNOLOGY |
Deregulation of the Kallikrein Protease Family in the Salivary Glands of the Sjögren’s Syndrome ERdj5 Knockout Mouse Model |
2021-07-07 |
10.3389/fimmu.2021.693911 |
Moustardas Petros, Yamada-Fowler Naomi, Apostolou Eirini, Tzioufas Athanasios G., Turkina Maria V., Spyrou Giannis |
713506 |
FRONTIERS IN IMMUNOLOGY |
Impact of Sex in the Efficacy of Perioperative Desensitization Procedures in Heart Transplantation: A Retrospective Cohort Study |
2021-07-07 |
10.3389/fimmu.2021.659303 |
Nguyen Lee S., Salem Joe-Elie, Bories Marie-Cécile, Coutance Guillaume, Amour Julien, Bougle Adrien, Suberbielle Caroline, Kheav Vissal-David, Carmagnat Maryvonnick, Rouvier Philippe, Kirsch Matthias, Varnous Shaida, Leprince Pascal, Saheb Samir |
713505 |
FRONTIERS IN IMMUNOLOGY |
Enhancing Checkpoint Inhibitor Therapy in Solid Tissue Cancers: The Role of Diet, the Microbiome & Microbiome-Derived Metabolites |
2021-07-07 |
10.3389/fimmu.2021.624434 |
Malczewski Agnieszka Beata, Ketheesan Natkunam, Coward Jermaine I. G., Navarro Severine |
713504 |
FRONTIERS IN IMMUNOLOGY |
ROS/RNS Balancing, Aerobic Fermentation Regulation and Cell Cycle Control – a Complex Early Trait (‘CoV-MAC-TED’) for Combating SARS-CoV-2-Induced Cell Reprogramming |
2021-07-07 |
10.3389/fimmu.2021.673692 |
Costa José Hélio, Mohanapriya Gunasekaran, Bharadwaj Revuru, Noceda Carlos, Thiers Karine Leitão Lima, Aziz Shahid, Srivastava Shivani, Oliveira Manuela, Gupta Kapuganti Jagadis, Kumari Aprajita, Sircar Debabrata, Kumar Sarma Rajeev, Achra Arvind, Sathishkumar Ramalingam, Adholeya Alok, Arnholdt-Schmitt Birgit |
713503 |
BMC RESEARCH NOTES |
De novo transcriptome assembly data for sengon (Falcataria moluccana) trees displaying resistance and susceptibility to boktor stem borers (Xystrocera festiva Pascoe) |
2021-07-07 |
10.1186/s13104-021-05675-9 |
Siregar Ulfah J., Nugroho Aditya, Shabrina Hasyyati, Indriani Fitri, Damayanti Apriliya, Matra Deden D. |
713502 |
ONCOLOGY LETTERS |
lnc‑NLC1‑C inhibits migration, invasion and autophagy of glioma cells by targeting miR‑383 and regulating PRDX‑3 expression |
2021-07-07 |
10.3892/ol.2021.12901 |
Xu Zhou, Chen Qianxue, Zeng Xingnuo, Li Mingchang, Liao Jianming |
713501 |
ONCOLOGY LETTERS |
Dysregulated expression of claudins in cancer (Review) |
2021-07-07 |
10.3892/ol.2021.12902 |
Li Jian |
713500 |
ONCOLOGY LETTERS |
Triple therapy with osimertinib, bevacizumab and cetuximab in EGFR‑mutant lung cancer with HIF‑1α/TGF‑α expression |
2021-07-07 |
10.3892/ol.2021.12900 |
Nishii Kazuya, Ohashi Kadoaki, Watanabe Hiromi, Makimoto Go, Nakasuka Takamasa, Higo Hisao, Ninomiya Kiichiro, Kato Yuka, Kubo Toshio, Rai Kammei, Ichihara Eiki, Hotta Katsuyuki, Tabata Masahiro, Maeda Yoshinobu, Kiura Katsuyuki |
713499 |
ONCOLOGY LETTERS |
Yes‑associated protein expression is associated with poor prognosis in patients with colorectal cancer |
2021-07-07 |
10.3892/ol.2021.12903 |
Cao Liyu, Zhang Cong, Wu Qingqing, Bai Zhenzhen, Chen Jing |